ICICI Prudential AMC IPO GMP, Subscription Status Live Updates: Bidding for the public issue of ICICI Prudential Asset Management Company reached its final day today, December 16. The Rs 10,602 crore public issue, which opened for subscription on December 12, is set to close later today.

The data indicates robust demand from institutional and shareholder segments, while retail participation is moderate as the IPO heads towards its final day.

Reports of a SpaceX public listing boost partner and investor stocks as the company prepares to pitch banks and target a $1.5 trillion valuation.

Medline Inc. is guiding prospective investors to expect its IPO to price in the upper half of the marketed range, according to people familiar with the matter, in what could be the year’s biggest listing.

The ICICI Prudential AMC issue is on its last day of subscription, having attracted nearly six times demand overall, led mainly by strong interest from non-institutional investors. Launched on December 12 within a price band of Rs 2,

Chinese AI chip startup Biren Technology aims to launch a Hong Kong initial public offering in the coming weeks, four sources with knowledge of the matter said.

KSH International's IPO opened for subscription on December 16, aiming to raise ₹710 crore. The price band is set between ₹365 and ₹384 per share, with a minimum investment of ₹14,720. The shares debut on BSE and NSE on December 23,

The company had a market capitalization of more than Rs 73,000 crore during its much-awaited market debut on 0. At today's high, the company's market capitalization stood at over Rs 87,000 crore.

Lo Toney, Plexo Capital, joins 'Closing Bell' to discuss SpaceX's IPO, if it opens the floodgates and much more.

ICICI Prudential AMC IPO sees 5.81x subscription on final day, fueled by strong interest from institutional and non-institutional investors.

Nephrocare Health IPO GMP at ₹38 signals an 8% listing premium as strong demand drives 14x subscription ahead of the stock's Dalal Street debut on December 17.